Review
Open access
Aug 2026
Recent Advances in Biomarkers of Systemic Sclerosis-Associated Interstitial Lung Disease: Clinical Relevance and Therapeutic Perspectives
This narrative review summarizes current evidence on established and emerging serum and molecular biomarkers in SSc-ILD and their potential clinical applications and highlights the potential of circulating and molecular biomarkers to refine risk stratification and prognostic assessment in SSc-ILD.
Rasha-Ioana Rămoiu-Shehada, A. Mușetescu, L. Florescu et al.
· Life · 0 citations